Table 2.
Gender | Organ | Dosage (mg/Kg. body weight) | MDA (nmol/g. tissue) | GSH (mg/g. tissue) | CAT (U/g. tissue) |
---|---|---|---|---|---|
Female | Liver | 50 | 5.48 ± 0.66 a | 6.24 ± 0.88a | 0.97 ± 0.07a |
100 | 6.71 ± 0.50b | 8.98 ± 0.62b | 1.12 ± 0.21a | ||
150 | 8.43 ± 1.88c | 12.21 ± 0.25c | 1.23 ± 0.07a | ||
Kidney | 50 | 3.28 ± 0.83a | 2.34 ± 0.23a | 1.01 ± 0.15a | |
100 | 4.76 ± 0.54b | 3.11 ± 0.63b | 0.97 ± 0.11a | ||
150 | 7.96 ± 0.58b | 3.29 ± 0.82b | 1.26 ± 0.05a | ||
Spleen | 50 | 4.84 ± 0.73a | 3.31 ± 0.56a | 0.65 ± 0.22a | |
100 | 5.99 ± 1.04b | 4.66 ± 0.35b | 0.73 ± 0.06a | ||
150 | 6.43 ± 0.71b | 4.99 ± 0.22b | 0.85 ± 0.10a | ||
Male | Liver | 50 | 4.33 ± 0.90a | 4.12 ± 0.99a | 1.10 ± 0.13a |
100 | 5.99 ± 1.43b | 7.14 ± 0.43b | 1.20 ± 0.15a | ||
150 | 7.81 ± 0.50c | 10.75 ± 0.78c | 1.29 ± 0.04a | ||
Kidney | 50 | 3.97 ± 0.57a | 2.69 ± 0.84a | 0.79 ± 0.11a | |
100 | 5.33 ± 0.67b | 3.12 ± 0.60b | 0.89 ± 0.08a | ||
150 | 6.47 ± 0.59b | 3.63 ± 0.02b | 0.92 ± 0.14a | ||
Spleen | 50 | 4.80 ± 0.55a | 3.54 ± 0.62a | 0.79 ± 0.21a | |
100 | 5.38 ± 0.41b | 4.58 ± 0.26b | 0.96 ± 0.13a | ||
150 | 5.67 ± 0.20b | 4.61 ± 0.69b | 1.01 ± 0.05a | ||
Effect of gender | Liver | P > 0.05 | P > 0.05 | P > 0.05 | |
Kidney | P > 0.05 | P > 0.05 | P > 0.05 | ||
Spleen | P > 0.05 | P > 0.05 | P > 0.05 | ||
Effect of Dosage | Liver | P < 0.05 | P < 0.05 | P > 0.05 | |
Kidney | P < 0.05 | P < 0.05 | P > 0.05 | ||
Spleen | P < 0.05 | P < 0.05 | P > 0.05 | ||
Interaction of gender and dosage | Liver | P > 0.05 | P > 0.05 | P > 0.05 | |
Kidney | P > 0.05 | P > 0.05 | P > 0.05 | ||
Spleen | P > 0.05 | P > 0.05 | P > 0.05 |
Values are mean ± SEM (n = 6).
Values within each gender and biochemical marker, different superscripted letters indicate significantly (P < 0.05) different values.